The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Virupaksha Organics Ltd

Promoter Stake BuyCreeping Acquisition Near ThresholdPromoter Below 50pctOwnership Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+14.9%Reaction day

₹108.75

prior close

₹122.00

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%+15.0% vs market

Pharmaceuticals peers, median of 151sector-0.3%+15.2% vs sector

On the reaction day the stock moved 15.0 pts more than Nifty Microcap 250 and 15.2 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.8

10m

+0.0

15m

+0.0

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+14.9-0.1+15.0-0.3+15.2

Next day

+14.6+1.3+13.3+0.4+14.2

+12.1+2.1+10.1+0.7+11.4

+14.0+2.5+11.5+1.7+12.3

+14.0+1.0+13.1+1.4+12.6

+14.0+0.6+13.4+1.1+12.9

+9.0-0.1+9.0-0.7+9.7

15d

+14.0+1.3+12.7-0.7+14.7

+6.7+2.1+4.6+0.7+5.9

-9.9-1.4-8.4-2.6-7.3

-32.4-0.1-32.3-3.3-29.1

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 151Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Virupaksha Organics Ltd, part of the promoter group of Oxygenta Pharmaceutical Ltd, has acquired 77,52,600 shares (20.96%) of the company through a Regulation 29(1) disclosure filed with BSE. Before this acquisition, Virupaksha Organics held 1,07,24,858 shares (29.00%); after the acquisition, its holding stands at 1,84,77,458 shares (49.96%). No encumbrance (pledge/lien) was involved, and the shares carry full voting rights. The acquirer is explicitly identified as belonging to the promoter/promoter group of Oxygenta Pharmaceutical Ltd.

Likely market impact

The promoter group's stake has risen sharply from 29% to just under 50%, signalling strong promoter confidence but also bringing them right up to the 50% threshold. Existing minority shareholders should note that promoter control is now near-absolute, which may reduce free float and could impact liquidity in the stock.